Ten payer pressures to act on now
Amy Hunckler, KPMG Strategy
Advertisement
Articles by Amy Hunckler, KPMG Strategy
Advertisement
Latest Updated Articles
- Specialty drug market access reality check
Published: September 1st 2016 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies
2
How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins
3
The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies
4
Pharma Pulse: Amgen's Uplizna Secures CD19 Approval for Myasthenia Gravis, as Asthma Biologic Switches Highlight Efficacy Expectations Gap
5
